Literature DB >> 32407306

Preliminary Estimate of Excess Mortality During the COVID-19 Outbreak - New York City, March 11-May 2, 2020.

.   

Abstract

SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), was first identified in December 2019 in Wuhan, China, and has since spread worldwide. On March 11, 2020, the World Health Organization declared COVID-19 a pandemic (1). That same day, the first confirmed COVID-19-associated fatality occurred in New York City (NYC). To identify confirmed COVID-19-associated deaths, defined as those occurring in persons with laboratory-confirmed SARS-CoV-2 infection, on March 13, 2020, the New York City Department of Health and Mental Hygiene (DOHMH) initiated a daily match between all deaths reported to the DOHMH electronic vital registry system (eVital) (2) and laboratory-confirmed cases of COVID-19. Deaths for which COVID-19, SARS-CoV-2, or an equivalent term is listed on the death certificate as an immediate, underlying, or contributing cause of death, but that do not have laboratory-confirmation of COVID-19 are classified as probable COVID-19-associated deaths. As of May 2, a total of 13,831 laboratory-confirmed COVID-19-associated deaths, and 5,048 probable COVID-19-associated deaths were recorded in NYC (3). Counting only confirmed or probable COVID-19-associated deaths, however, likely underestimates the number of deaths attributable to the pandemic. The counting of confirmed and probable COVID-19-associated deaths might not include deaths among persons with SARS-CoV-2 infection who did not access diagnostic testing, tested falsely negative, or became infected after testing negative, died outside of a health care setting, or for whom COVID-19 was not suspected by a health care provider as a cause of death. The counting of confirmed and probable COVID-19-associated deaths also does not include deaths that are not directly associated with SARS-CoV-2 infection. The objective of this report is to provide an estimate of all-cause excess deaths that have occurred in NYC in the setting of widespread community transmission of SARS-CoV-2. Excess deaths refer to the number of deaths above expected seasonal baseline levels, regardless of the reported cause of death. Estimation of all-cause excess deaths is used as a nonspecific measure of the severity or impact of pandemics (4) and public health emergencies (5). Reporting of excess deaths might provide a more accurate measure of the impact of the pandemic.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32407306     DOI: 10.15585/mmwr.mm6919e5

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  72 in total

1.  The Hidden Curriculum of the COVID-19 Pandemic.

Authors:  Mena Botros; Avraham Z Cooper
Journal:  J Grad Med Educ       Date:  2020-10

2.  First in the Nation: Washington State's Long-Term Care Trust Act.

Authors:  Laurie Jinkins
Journal:  Milbank Q       Date:  2019-12-19       Impact factor: 4.911

3.  Estimation of Excess Deaths Associated With the COVID-19 Pandemic in the United States, March to May 2020.

Authors:  Daniel M Weinberger; Jenny Chen; Ted Cohen; Forrest W Crawford; Farzad Mostashari; Don Olson; Virginia E Pitzer; Nicholas G Reich; Marcus Russi; Lone Simonsen; Anne Watkins; Cecile Viboud
Journal:  JAMA Intern Med       Date:  2020-10-01       Impact factor: 21.873

4.  Estimating under-recognized COVID-19 deaths, United States, march 2020-may 2021 using an excess mortality modelling approach.

Authors:  A Danielle Iuliano; Howard H Chang; Neha N Patel; Ryan Threlkel; Krista Kniss; Jeremy Reich; Molly Steele; Aron J Hall; Alicia M Fry; Carrie Reed
Journal:  Lancet Reg Health Am       Date:  2021-07-13

5.  COVID-19-associated Parotid Gland Abscess.

Authors:  Reinhard E Friedrich; Tabea-Luise Droste; Fabian Angerer; Bogdan Popa; Robert Koehnke; Martin Gosau; Christian Knipfer
Journal:  In Vivo       Date:  2022 May-Jun       Impact factor: 2.406

6.  COVID-19 and Overall Mortality Inequities in the Surge in Death Rates by Zip Code Characteristics: Massachusetts, January 1 to May 19, 2020.

Authors:  Nancy Krieger; Pamela D Waterman; Jarvis T Chen
Journal:  Am J Public Health       Date:  2020-10-15       Impact factor: 9.308

7.  Prioritizing High-Value, Equitable Care After the COVID-19 Shutdown: An Opportunity for a Healthcare Renaissance.

Authors:  Reshma Gupta; Lisa A Simpson; Daniel J Morgan
Journal:  J Hosp Med       Date:  2021-02       Impact factor: 2.960

8.  Estimating COVID-19 mortality in Italy early in the COVID-19 pandemic.

Authors:  Vanessa Böhm; Simone Ferraro; Chirag Modi; George Stein; Uroš Seljak
Journal:  Nat Commun       Date:  2021-05-12       Impact factor: 14.919

9.  Temporal dynamic in the impact of COVID- 19 outbreak on cause-specific mortality in Guangzhou, China.

Authors:  Li Li; Dong Hang; Han Dong; Chen Yuan-Yuan; Liang Bo-Heng; Yan Ze-Lin; Yang Zhou; Ou Chun-Quan; Qin Peng-Zhe
Journal:  BMC Public Health       Date:  2021-05-08       Impact factor: 3.295

10.  The differential demographic pattern of coronavirus disease 2019 fatality outside Hubei and from six hospitals in Hubei, China: a descriptive analysis.

Authors:  Qing-Bin Lu; Hai-Yang Zhang; Tian-Le Che; Han Zhao; Xi Chen; Rui Li; Wan-Li Jiang; Hao-Long Zeng; Xiao-Ai Zhang; Hui Long; Qiang Wang; Ming-Qing Wu; Michael P Ward; Yue Chen; Zhi-Jie Zhang; Yang Yang; Li-Qun Fang; Wei Liu
Journal:  BMC Infect Dis       Date:  2021-05-26       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.